UPM Institutional Repository

Plasma and cell lysate proteins associated with treatment outcome in acute myeloid leukaemia


Citation

Barantalab, Fatemeh and Chong, Pei Pei and Lee, Cindee and Yiau, Stephnie Kang Xian and Chang, Kian Meng and Seman, Zainina and Abdullah, Maha (2020) Plasma and cell lysate proteins associated with treatment outcome in acute myeloid leukaemia. Malaysian Journal of Medicine and Health Sciences, 16 (2). pp. 23-29. ISSN 1675-8544; ESSN: 2636-9346

Abstract

Introduction: Drug-resistance is a major hindrance to successful treatment of AML. Current predictive biomarkers are mainly genetic aberrations and insufficient in foretelling treatment outcome in all acute myeloid leukaemia (AML) due to its heterogeneous and aggressive nature. Proteins are stable and reliable. Secreted proteins in AML may have predictive or prognostic values for early intervention. Proteomic studies on AML are few and further investigations will benefit in selection of best markers. The aim of the study was to identify differentially expressed plasma proteins in AML with different treatment outcome. Methods: Two-dimensional electrophoresis (2-DE) technique was utilised to identify proteins differentially expressed in chemo-sensitive/chemo-resistant AML. Plasma and peripheral blood mononuclear cell (PBMC) lysate proteome analysis were performed on six chemo-resistant, four chemo-sensitive and six healthy controls and seven chemo-resistant, three chemo-sensitive and six healthy controls, respectively. Each experiment was conducted in duplicate or triplicate. Images were captured and protein spots detected by software. Differentially expressed protein spots were excised from gel and proteins were identified using LC/MS/MS. Proteins spots that were also detected in healthy controls were excluded. Results: Comparing mean % volume of each spot demonstrated significantly enhanced expression of apoliprotein-E (APO-E) and haptoglobin (HP) (p<0.05) in plasma and HNRNP H1 (p=0.049) in cell lysate of chemo-sensitive group. Serotransferrin (STF) from plasma and DNA-PK from cell lysate (p=0.01) were associated with chemo-resistance. Conclusion: This preliminary study identified sever-al potential predictive biomarkers associated with chemo-resistance/chemo-sensitivity to treatment in AML. Further studies with a larger number of samples are required to validate the results.


Download File

[img] Text
2020042010054504_MJMHS_0245.pdf

Download (585kB)

Additional Metadata

Item Type: Article
Divisions: Faculty of Medicine and Health Science
Institute of Bioscience
Publisher: Faculty of Medicine and Health Sciences, Universiti Putra Malaysia
Keywords: Proteomics; Acute myeloid leukaemia; Two-dimensional electrophoresis; Mass spectrometry; Chemo-resistance
Depositing User: Nabilah Mustapa
Date Deposited: 04 May 2020 17:39
Last Modified: 04 May 2020 17:39
URI: http://psasir.upm.edu.my/id/eprint/77930
Statistic Details: View Download Statistic

Actions (login required)

View Item View Item